SiO2 Materials Science receives $143M U.S. government contract for vaccine packaging scale-up

SiO2 Materials Science announced a $143 million agreement with the U.S. Department of Defense and BARDA to accelerate production scale-up of its primary packaging platform for COVID-19 vaccines and therapeutics. The platform uses a plastic container with a microscopic glass coating.

“The nation can produce all the vaccines we want, but we must have appropriate containers to store them and deliver them to patients safely.”biospace.com

• 1 source
• biospace.comSiO2 Materials Science Receives $143 Million Contract from U.S. Government to Accelerate Capacity Scale-Up of Advanced Primary Packaging Platform for COVID-19 Vaccines and Therapeutics - BioSpaceAnnalee ArmstrongJun 8, 2020

Summarized from public sources; check the original articles before acting on it.